Union, NJ, United States of America

James P Gilligan

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 3 EPO patents, primarily in Peptide Pharmaceuticals. Top assignees: Unigene Laboratories Inc., Yale University, Enteris Biopharma, Inc.. Active years: 1987-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James P Gilligan. Retrieved from https://idiyas.com/inventor/james-p-gilligan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 54.2

 

 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 274(Granted Patents)


Location History:

  • Elizabeth, NJ (US) (1987)
  • Linden, NJ (US) (2004)
  • Northport, NY (US) (2012)
  • Union, NJ (US) (1998 - 2016)
  • Denville, NJ (US) (2022 - 2024)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Calcitonin Formulation
Bone Growth
Peptide Delivery
Oral Pharmaceutical
Enzymatic Reactions
Obesity Treatment
Alpha-Amidation
Pharmaceutical Compositions
Therapeutic Products
Emergency Kit
Keto Acids
Inflammatory Diseases
24 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would be happy to help provide information on inventor James P Gilligan.

Title: James P Gilligan: Pioneering Inventor in the World of Technology

Introduction: James P Gilligan is a renowned inventor based in Union, NJ, United States. With a passion for innovation and a dedication to creating impactful solutions, he has solidified his reputation as a pioneering inventor in the world of technology.

Latest Patents:

1. Room Temperature Stable Oral Calcitonin Formulation: James P Gilligan's patented invention includes dosage forms for oral delivery of calcitonin with low water content, along with room-temperature stable dosage forms. These innovations offer new methods for producing stable and effective dosage forms for the administration of calcitonin.

2. Oral Delivery of Peptide Pharmaceutical Compositions: Another groundbreaking patent by James P Gilligan involves enhancing the bioavailability of peptide active agents for oral administration. By combining the pharmaceutical composition with an absorption enhancer and utilizing an acid-resistant protective vehicle, the bioavailability of the peptide is significantly increased, leading to more efficient treatment outcomes.

Career Highlights: With a total of 21 patents to his name, James P Gilligan has demonstrated a strong commitment to innovation in the field of technology. His inventions have paved the way for advancements in oral drug delivery systems and pharmaceutical compositions.

Collaborations: Throughout his career, James P Gilligan has collaborated with esteemed colleagues such as Nozer M Mehta and William Stern. Together, they have furthered research and development in the realm of pharmaceutical innovations and drug delivery mechanisms.

Conclusion: James P Gilligan's innovative spirit and dedication to creating impactful solutions have established him as a pioneering inventor in the world of technology. With numerous patents to his name and a history of successful collaborations, he continues to drive innovation and make significant contributions to the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…